Pain Outcomes Comparing Yoga Versus Structured Exercise (POYSE) Trial (POYSE)
10 février 2020 mis à jour par: VA Office of Research and Development
The Pain Outcomes comparing Yoga versus Structured Exercise (POYSE) Trial is a 2-arm parallel group, randomized clinical trial to compare the effectiveness of a yoga-based intervention (YOGA) with that of a structured exercise program (SEP) for subjects with fibromyalgia.
The study aims are: 1) to compare the interventions' (YOGA vs. SEP) effects on overall fibromyalgia severity at 1 month (early response), 3 months (immediate post-intervention) and at 6 and 9 months (sustained effects); 2) to compare the interventions effects on specific fibromyalgia symptoms (pain, sleep, and fatigue), functional impairment, and related outcomes (quality of life, psychological symptoms); and 3) to compare the cost-effectiveness of the interventions.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Description détaillée
This study sample will include 306 Veterans with fibromyalgia.
Patients will be randomized to one of two treatment arms.
The YOGA arm will involve a standardized 12-week, yoga-based intervention.
The yoga intervention will consist of three treatment components: 1) in-person group yoga taught by a certified yoga therapist; 2) a relaxation audio recording for home-use; and 3) a DVD recording to reinforce concepts taught during in-person yoga sessions.
Patients randomized to the structured exercise program (SEP) arm will participate in a 12-week exercise program delivered in a group/class format and supervised by a fitness instructor.
In addition, SEP patients will receive a DVD (for home use) describing the benefits of aerobic exercise for fibromyalgia, a one-on-one consultation session with the fitness instructor, an individualized exercise prescription, and supervised exercise sessions for 12 weeks.
Type d'étude
Interventionnel
Inscription (Réel)
256
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Indiana
-
Indianapolis, Indiana, États-Unis, 46202-2884
- Richard L. Roudebush VA Medical Center, Indianapolis, IN
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans et plus (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
Veterans will be eligible if they have:
- Widespread Pain Index (WPI) greater than 7 and Symptom Severity Scale (SS) greater than 5 or WPI 3-6 and SS greater than 9.
- Symptoms have been present at a similar level for at least 3 months
- The subject does not have a disorder that would otherwise explain the pain
- Moderate pain severity (pain severity score greater than 5)
- No changes in fibromyalgia medications for last 4 weeks
- Access to a working telephone
Exclusion Criteria:
Exclusion criteria includes:
- Severe medical conditions in which exercise is contraindicated (such as significant cardiovascular disease, COPD or asthma needing home oxygen, stroke or TIA in last 6 months, cancer (other than skin cancer) and receiving treatment for it
- Active psychosis
- Hospitalized for psychiatric reasons within the last 6 months
- Active suicidal ideation
- Moderate to severe cognitive impairment
- Involvement in ongoing yoga classes or moderately intense exercise program in the last 3 months
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Yoga
A 12-week yoga intervention modified for Veterans with fibromyalgia.
Each weekly session will last approximately 75 minutes.
The standardized sequence of yoga poses will be introduced to participants and the instructor will tailor them to the participant's needs and abilities.
Deep breathing exercises will be taught and emphasized throughout every session.
Participants will be encouraged to exercise according to their limits, rather than rigid adherence to posture techniques.
The yoga intervention will be tailored to the individual.
It will include low intensity, low impact modified poses adapted with pathophysiologic changes of fibromyalgia in mind.
Participants will also be given a Playaway(c) device with guided relaxation exercise recorded on it and asked to listen to it three times a week to reinforce the in person yoga session content.
|
A 12-week yoga intervention modified for Veterans with fibromyalgia.
Each weekly session will last approximately 75 minutes.
The standardized sequence of yoga poses will be introduced to participants and the instructor will tailor them to the participant's needs and abilities.
Deep breathing exercises will be taught and emphasized throughout every session.
Participants will be encouraged to exercise according to their limits, rather than rigid adherence to posture techniques.
The yoga intervention will be tailored to the individual.
It will include low intensity, low impact modified poses adapted with pathophysiologic changes of fibromyalgia in mind.
Participants will also be given a Playaway(c) device with guided relaxation exercise recorded on it and asked to listen to it three times a week to reinforce the in person yoga session content.
|
|
Comparateur actif: Structured Exercise
A 12-week group exercise session consisting of a graded aerobic exercise program.
The program will start at low intensity with gradual increases in exercise intensity and duration.
Each weekly session will last 75 minutes.
The fitness instructor will teach participants to use a table-top ergometer at a sub-maximal level, determine baseline fitness, and develop an individualized exercise prescription.
The fitness instructor will provide educational tips on exercise and selection of physical activities.
Participants will be given a pedometer and heart rate monitor to track their exercise at home.
They will also be given an exercise DVD to use at home.
|
A 12-week group exercise session consisting of a graded aerobic exercise program.
The program will start at low intensity with gradual increases in exercise intensity and duration.
Each weekly session will last 75 minutes.
The fitness instructor will teach participants to use a table-top ergometer at a sub-maximal level, determine baseline fitness, and develop an individualized exercise prescription.
The fitness instructor will provide educational tips on exercise and selection of physical activities.
Participants will be given a pedometer and heart rate monitor to track their exercise at home.
They will also be given an exercise DVD to use at home.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Fibromyalgia Impact Questionnaire Revised (FIQR) Total Score
Délai: 3 month
|
This measure will be assessed at Baseline, 1, 3, 6 and 9 months.
The 3 month is the primary end point and the 6 and 9 month assessments are for sustained effect.
Min:0, Max: 90.
Higher Score = Worse Outcome.
|
3 month
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Fibromyalgia Impact Questionnaire-Revised Difficulty Subscale
Délai: 3 Month
|
This represents a subscale of the FIQr and measures patient perceived difficulty related to fibromyalgia.
Min:0, Max: 20.
Higher Score = Worse Outcome.
|
3 Month
|
|
Fibromyalgia Impact Questionnaire-Revised Impact Subscale
Délai: 3 Month
|
This is a subscale of the FIQr and measures the overall impact of fibromyalgia symptoms.
Min:0, Max: 100.
Higher Score = Worse Outcome.
|
3 Month
|
|
Fibromyalgia Impact Questionnaire Revised Symptoms Subscale
Délai: 3 Month
|
This subscale of the FIQr provides an overall fibromyalgia symptom score.
Min:0, Max: 100.
Higher Score = Worse Outcome
|
3 Month
|
|
Brief Pain Inventory (BPI) Severity Subscale
Délai: 3 month
|
is an 11-item, multidimensional pain measurement tool with demonstrated reliability in patients with arthritis as well as other pain conditions.
The BPI rates the intensity of pain as well as the interference of pain with mood, physical activity, work, social activity, relations with others, sleep, and enjoyment of life.Min:0, Max: 40.
Higher Score = Worse Outcome.
|
3 month
|
|
PHQ-9 for Depression
Délai: 3 Month
|
will be used to assess depression severity.
Several studies have validated the PHQ-9 as a diagnostic measure with excellent psychometric properties.
Internal consistency has consistently been shown to be high (Cronbach's alpha > 0.80) and test-retest assessment showed the PHQ-9 to be a responsive and reliable measure of depression treatment outcomes.
Min:0, Max: 27.
Higher Score = Worse Outcome.
|
3 Month
|
|
GAD-7 Anxiety Scale
Délai: 3 Month
|
This 7-item scale represent a measure of anxiety symptom severity and provides a score from 0 to 21 with higher scores representing more severe anxiety
|
3 Month
|
|
PTSD Checklist of Symptoms
Délai: 3 Month
|
This 17-item scale assess PTSD symptom severity and provides a severity score; with higher scores representing more severe PTSD.
Min: 0, Max: 85 with higher scores representing more severity.
|
3 Month
|
|
SF-12 Physical Score (Health-related Quality of Life)
Délai: 3 Month
|
The SF-12 is a well-validate measure of health-related quality of life; providing a physical and mental health component summary score.
Min:0, Max: 100.
Higher Score = Worse Outcome.
|
3 Month
|
|
SF-12 Mental Score (Health-related Quality of Life)
Délai: 3 Month
|
The SF-12 is a well-validate measure of health-related quality of life; providing a physical and mental health component summary score.
Min:0, Max: 100.
Higher Score = Worse Outcome.
|
3 Month
|
|
Multi-dimensional Fatigue Inventory
Délai: 3 Month
|
This scale assesses overall fatigue and has been well-validated and used in other fibromyalgia trials.
Min:0, Max: 100.
Higher Score = Worse Outcome.
|
3 Month
|
|
MOS Sleep Scale - Problems Index
Délai: 3 Month
|
This scale assesses different aspects of sleep quality and provides an overall index with higher scores representing more severe sleep problems.
Min:0, Max: 100.
Higher Score = Worse Outcome.
|
3 Month
|
|
Pain Catastrophizing Scale
Délai: 3 Month
|
This 13-item scale assesses pain catastrophizing which has been found to be a predictor of poor treatment response.
Min: 0. Max: 52.
Higher Score = Worse Outcome.
|
3 Month
|
|
Arthritis Self-efficacy Scale
Délai: 3 Month
|
This scale has been well-validated to assess self-efficacy or confidence in a person's ability to complete a task.
Min: 0, Max: 60.
Higher score represents improvement.
|
3 Month
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
1 août 2013
Achèvement primaire (Réel)
2 juillet 2018
Achèvement de l'étude (Réel)
31 décembre 2018
Dates d'inscription aux études
Première soumission
20 février 2013
Première soumission répondant aux critères de contrôle qualité
20 février 2013
Première publication (Estimation)
22 février 2013
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
24 février 2020
Dernière mise à jour soumise répondant aux critères de contrôle qualité
10 février 2020
Dernière vérification
1 février 2020
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- D1100-R
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Non
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
produit fabriqué et exporté des États-Unis.
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .